Tuesday, July 17, 2018
News
NEWS HOME
»
PRESS RELEASES

Ferring and the Chinese Academy of Sciences Collaborate to Advance Research in Reproductive Medicine
  SocialTwist Tell-a-Friend  
   


Date: 12-01-2018 12:50PM
Source: Ferring Pharmaceuticals
Category: General, Science & Research, Banking & Financial Services, Education & Training, Healthcare & Biotechnology, Pharmaceutical, Business Services, Technology
Location: Saint-Prex, Switzerland

Business Wire India

Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180110006148/en/

As part of the agreement, a new jointly funded laboratory will be created within the CAS research facility in Beijing, China. Known as the ‘Ferring Institute of Reproductive Medicine’, the facility will bring together researchers from both Ferring and CAS to find solutions to address global challenges in fertility and high rates of obstetric complications.

“Across the world, too many couples still face considerable challenges when trying to become families,” said Per Falk, Executive Vice President and Chief Scientific Officer, Ferring Pharmaceuticals. “This collaboration forms the next phase in our ongoing efforts to advance knowledge and care in reproductive medicine and women’s health. Working together we hope to gain a deeper understanding of fertility and implantation and discover new solutions that could transform the way in which reproductive medicine is managed in the future.”

“Our collaboration with Ferring will expand our research base into the translational space and together we will rapidly expand our tool set to look at truly transformational ideas in reproductive medicine,” said Prof Hongmei Wang, Director of the State Key Laboratory of Stem Cell and Reproductive Biology at the Institute of Stem Cell and Regeneration, Chinese Academy of Sciences.

For CAS, the collaboration will provide additional expertise and funding to support their world-class stem cell research and regenerative medicine programme, a core element of their Innovation 2030: Building Tomorrow initiative. For Ferring, the collaboration will help to identify new therapeutic concepts and targets that will enable the discovery of novel drug candidates that may be further developed to address unmet needs in reproductive medicine and women’s health.

“CAS is already recognised as a leading life science institute for our early basic research in reproductive biology, which covers most aspects of female and male infertility and obstetric complications,” said Prof Qi Zhou, Director of the Institute of Stem Cell and Regeneration and the Institute of Zoology, Chinese Academy of Sciences. “We welcome this collaboration which will help us to reach our Innovation 2030 goal and improve reproductive health both in China and worldwide.”

- Ends -

About Ferring Pharmaceuticals:

Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. A leader in reproductive medicine and women’s health, Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative treatments to help mothers and babies, from conception to birth. The company also identifies, develops and markets innovative products in the areas of urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com.

Ferring is on Twitter. Follow us @FerringNews at http://twitter.com/FerringNews

About the Chinese Academy of Sciences (CAS):

The Chinese Academy of Sciences (CAS) is the largest national research organisation in China focused on exploring and harnessing technology and the natural sciences for the benefit of China and the world. CAS comprises 104 research institutes, containing in excess of 300 national and CAS key labs and engineering centres, 12 branch academies, three universities and 11 supporting organisations in 23 provincial-level areas across the country. With over 68,000 researchers, CAS brings together scientists and engineers from China and around the world to conduct research in most areas of breakthrough science and technology.


MULTIMEDIA AVAILABLE :
http://www.businesswire.com/news/home/20180110006148/en/


CONTACTS :

Ferring Corporate Communications Team:
Lindsey Rodger
Senior Manager, Corporate Communications
+41 58 451 4023 (direct)
+41 79 191 0486 (mobile)
lindsey.rodger@ferring.com
or
Bhavin Vaid
Head of Corporate Communications
+41 58 301 0952 (direct)
+41 79 191 0632 (mobile)
bhavin.vaid@ferring.com
or
Chinese Academy of Sciences:
Wei Li
Vice Director, Corporate Communications
+86-10-64807297 (direct)
+86-15210478009 (mobile)
liwei@ioz.ac.cn

More Press Releases

The Countdown Begins to the One of Biggest Outbound- MICE & Luxury Travel Platform

Fischer & Schickendantz and Solution Alliance SRL Adopt Andersen Brand in Uruguay

Is India Ready for August 4 Trade Scrimmage, Asks the Forum of Indian Food Importers

Pidilite Strengthens Its International Presence; Unveils a State-of-the-Art Adhesive Manufacturing Plant in Srilanka

BMW India Extends Special Service Support for Flood-affected Customers in Mumbai

Bank of America Reports Second-Quarter 2018 Financial Results

Alipay and Singapore Tourism Board join hands to boost Chinese tourist spending

New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery

IUIH Invites ICT Enterprises to Deliver Over 1 Billion USD Worth of IT Infra and Services for Its Digital Hospitals and Clinics

TIME CyberMedia Concludes Its 3rd International Healthcare Awards, 2018 & Conference in New Delhi

RG Stone Discusses the Causes and Treatment Options for Kidney Stones During Pregnancy

Rolls-Royce Motor Cars Announces New Regional PR & Communications Manager for Middle East, Africa & India

Prudent Corporate Advisory Services Offering Minority Stake to TA Associates

Market Xcel Enters the Big Data Analytics Arena

TA Associates Announces Minority Investment in Prudent Corporate Advisory Services

Wipro Cited as a Leader in Gartner’s Magic Quadrant for Data Center Outsourcing and Hybrid Infrastructure Managed Services, North America

MetLife Selects Lucep as Winner of collab 3.0 EMEA

Contactless Technology Powers Fifty Percent of Purchases at 2018 FIFA World Cup Russia™

Brazil Approves AerSafe for Airbus 321 Aircraft to Comply with Fuel Tank Flammability Reduction Rule

Toyoda Gosei Enhances Technical Development Operations in India

Blockchain-based Adents NovaTrack Issues Token to Standardize Access to Comprehensive Supply Chain Traceability

See Where the Future Unfolds at the IBC2018 Leaders’ Forum

Croatia, STATS’ First World Cup Team Customer with STATS Edge™, Goes on Historic Run to Final

 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
INDIA WORLD ASIA
See whether new law can be formed on cow...
France's Giroud savours World Cup glory ...
Major currencies down...
11 Automatic air quality monitoring stat...
As sanctions start to bite, Iran crude e...
Asia stocks sag on oil's slide, dollar d...
More...    
 
 Top Stories
Major currencies down... 
11 Automatic air quality monitoring... 
As sanctions start to bite, Iran cr... 
Asia stocks sag on oil's slide, dol... 
SFI activist hacked in Kozhikode... 
TV & film actor Rita Bhaduri dies, ... 
Partly cloudy morning in Delhi... 
See whether new law can be formed o...